Ohio Admin. Code 5123-6-06 - Qualifications, training, and certification of developmental disabilities personnel who perform health-related activities and administer prescribed medication
(A)
Purpose
This rule sets forth eligibility and requirements for three types of training programs and resulting certification held by developmental disabilities personnel:
(1)
Health-related
activities and prescribed medication administration;
(2)
Prescribed
medication administration through gastrostomy and jejunostomy tube by nursing
delegation; and
(3)
Administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing
delegation.
(1) To be eligible to
take a training program described in paragraph (B)
(C) of this rule,
developmental disabilities personnel shall
will:
(a) Be at
least eighteen years of age;
(b)
Hold a high school diploma or general education development certificate;
and
(c) Be able to read, write, and
understand English at a level sufficient to comply with all requirements set
forth in administrative rules governing the services provided.
(2) Prior to permitting
developmental disabilities personnel to enroll in a training program described
in paragraph (B)
(C) of this rule, the registered nurse trainer
shall
will,
as applicable:
(a) Secure an attestation from
the employer of developmental disabilities personnel that the developmental
disabilities personnel has been subject to a completed background check conducted in accordance
with rule
5123-2-02 of the Administrative
Code with results received; or
(b) Verify that the developmental
disabilities personnel holds independent provider certification issued by the
department.
(1)
Health-related activities and prescribed medication administration training
program
(a) A health-related activities and
prescribed medication administration training program provided pursuant to this
rule, to prepare developmental disabilities personnel to perform health-related
activities, administer oral prescribed medication, administer topical
prescribed medication, administer topical over-the-counter musculoskeletal
medication, and administer oxygen and metered dose inhaled medication,
shall
will be
at a minimum a fourteen-hour course; one hour equals sixty minutes of classroom
instruction. Relevant agency-specific and/or facility-specific material may be
added to the department-approved curriculum described in paragraph
(B)(1)(c)
(C)(1)(c) of this rule only with additional
corresponding classroom instruction time beyond the fourteen-hour
course.
(b) The department may
authorize a registered nurse trainer to provide a portion of the health-related
activities and prescribed medication administration training program by
audio-visual distance learning. The department's authorization will be based
upon review and approval of a training program syllabus and supporting
documentation submitted by the registered nurse trainer that demonstrate the
audio-visual distance learning meets the following requirements:
(i) The registered nurse trainer will develop
a syllabus that:
(a) Outlines specific content
and number of hours of the training program to be conducted by audio-visual
distance learning and by in-person classroom instruction;
(b) Describes methods for providing students
with training manuals and materials;
(c) Reflects incorporation of evidence-based
principles of adult learning in the instructional design;
(d) Includes interactive learning activities
to achieve student engagement with the registered nurse trainer and other
students;
(e) Describes methods to
be used by the registered nurse trainer to verify student comprehension of
information and skills;
(f) Sets
forth that a student will complete the return demonstration of proficiency, including transcription, described in paragraph
(D)(1)(c)
(E)(1)(c) of this rule, the written examination
described in paragraph (D)(1)(d)
(E)(1)(d) of this rule, and the evaluation of the
training program described in paragraph (D)(1)(e)
(E)(1)(e)
of this rule during the in-person classroom instruction portion of the training
program; and
(g) Provides
sufficient detail to demonstrate how the requirements set forth in paragraphs
(B)(1)(b)(ii) and (B)(1)(b)(iii)
(C)(1)(b)(ii) and (C)(1)(b)(iii) of this rule
will be met.
(ii)
Audio-visual distance learning will be conducted using conferencing software
that provides for:
(a) Two-way audio and video
interactive capability by all participants;
(b) All participants to see one another
including each participant's face and upper body from the desktop and
above;
(c) The registered nurse
trainer to share and present materials on screen;
(d) A private chat feature that enables a
student to chat with the registered nurse trainer and ask questions if
muted;
(e) Authenticated log-on by
participants;
(f) An enabled
waiting room so that the registered nurse trainer controls admission of
students;
(g) The registered nurse
trainer to track a student's attendance and presence in the meeting
room;
(h) Prevention of anyone
other than the registered nurse trainer from recording the training program;
and
(i) The registered nurse
trainer to control and disable a student's audio and video capability and
remove a student when necessary.
(iii) The registered nurse trainer is
responsible for ensuring:
(a) A student's
video monitor is large enough to allow clear visualization of the registered
nurse trainer, the presented materials, and demonstrations. Neither a student
nor the registered nurse trainer is permitted to participate in the
audio-visual distance learning via a hand-held cellular telephone.
(b) The class size is such that the
registered nurse trainer clearly visualizes each student on the registered
nurse trainer's video monitor.
(c)
A student experiencing technical difficulties with the audiovisual conferencing
software is not considered in attendance for that portion of the training
program.
(c)
The health-related activities and prescribed medication administration training
program shall
will address:(ix)(viii) Instruction in
safe storage and transport of oxygen.
(x)(xviii) Instruction in
the use of pulse oximetry to accurately record an individual's oxygen
saturation as prescribed by a licensed health professional authorized to
prescribe drugs.
(xi)(xix) Instruction in
the use of continuous positive airway pressure machines, including biphasic
positive airway pressure machines, for the
intermittent delivery of continuous positive
airway pressure to treat obstructive sleep apnea or sleep-related
hypoventilation as prescribed by a licensed health professional authorized to
prescribe drugs.
(xii)(xx) Instruction in
the application of percussion vests to promote airway secretion clearance as
prescribed by a licensed health professional authorized to prescribe
drugs.
(xiii)(xxi) Instruction in
the use of cough assist devices and insufflators to promote the removal of
airway secretions in those with respiratory muscle weakness as prescribed by a
licensed health professional authorized to prescribe drugs.
(xiv)(xxii) Instruction in
the use of metered dose inhaled medication administered by a hand-held
dispenser and the use of an aerosol nebulizer to administer a pre-measured
medication for the treatment of asthma or other respiratory condition as
prescribed by a licensed health professional authorized to prescribe
drugs.
(xv)(xxiii) Information
and instruction in responsibility of developmental disabilities personnel for
following the step-by-step procedures for administration of all medication and
performance of health-related activities and completing additional training
before attempting any action for which the developmental disabilities personnel
is not competent.
(xvi)(xxiv) Information
and instruction in responsibility of developmental disabilities personnel for
knowing the purpose of medication and health-related activities being performed
or administered and facilitating the reporting of problems, including lack of
effectiveness and potential side effects, to a healthcare
professional.
(xvii)(xxv) Instruction in
quality measures, including but not limited to, procedures for reporting and
documenting medication/treatment errors that may occur when performing
health-related activities, administering oral prescribed medication,
administering topical prescribed medication, administering topical
over-the-counter musculoskeletal medication, and administering oxygen and
metered dose inhaled medication.
(xviii)(xxvi) Procedures
to be followed in case of medication emergency including when, why, and how to
contact the employer of developmental disabilities personnel or designee, a
healthcare professional, or the supervising licensed nurse when medication is
administered or a nursing task is performed pursuant to nursing
delegation.
(xix)(xxvii) Information
about what developmental disabilities personnel may be authorized to perform
with respect to administering oral prescribed medication, administering topical
prescribed medication, administering topical over-the-counter musculoskeletal
medication, or administering oxygen and metered dose inhaled
medication.
(xx)(xxviii) Limitations
with respect to "as needed" (or "PRN") prescribed medication, which state that
developmental disabilities personnel shall
will not administer a prescribed medication
ordered by a physician or other licensed health professional authorized to
prescribe drugs when the prescribed medication is to be administered as needed,
unless the order is written with specific parameters which preclude independent
judgment.
(xxi)(xxix) Limitations
with respect to over-the-counter medication which include the need for a
prescription from a licensed health professional authorized to prescribe drugs
to administer all over-the-counter medication not authorized for administration
by developmental disabilities personnel pursuant to section
5123.42 of the Revised
Code.
(xxii)(xxx) The
requirement for specialized training pursuant to this rule for the
administration of topical over-the-counter medication for the purpose of
cleaning, protecting, or comforting the skin, hair, nails, teeth, or oral
surfaces.
(xxiii)(xxxi) Instruction
in the use of topical over-the-counter musculoskeletal medication.
(xxiv)(xxxii) Information
about what developmental disabilities personnel are prohibited from
administering, which includes but is not limited to:
(xxv)(xxxiii) Instruction
in the use of commercially packaged rectal diazepam gel for the treatment of
epilepsy as prescribed by a licensed health professional authorized to
prescribe drugs.
(xxvi)(xxxiv) Instruction
in the use of commercially packaged glucagon for the treatment of hypoglycemia
as prescribed by a licensed health professional authorized to prescribe drugs.
Teaching must be completed and nursing delegation must be in place prior to
administration of glucagon.
(xxvii)(xxxv) Instruction
in potential drug reactions, including known side effects, interactions, and
the proper course of action if a side effect occurs, and sources for prescribed
medication information (such as pharmacist, physician, nurse, or poison control
center).
(xxviii)(xxxvi) The
requirements for documentation of prescribed medication administered, missed,
held, or refused
declined to, by, or for each individual.
(xxix)(xxxvii) The
definition of a medication/treatment error and requirements for documentation
and notification of unusual incidents and major unusual incidents related to
medication/treatment errors.
(xxx)(xxxviii) Information
regarding the appropriate and secure storage and care of prescribed
medication.
(xxxi)(xxxix) Instruction
that in settings where developmental disabilities personnel are administering
prescribed medication, with or without nursing delegation, medication may be
administered only from pharmacy-labeled or manufacturer-labeled containers and
only by the person who prepared the dosage from those containers.
(xxxii)(xl) Information
and instruction about who may receive and who may transcribe physician orders
and prescriptions into a prescribed
on to a medication administration record or
treatment administration record specific to each category pursuant to rule
5123:2-6-03
5123-6-03 of the Administrative Code.
(xxxiii)(xli) Performance
of a successful return demonstration for each route of prescribed medication
administration in which developmental disabilities personnel are
trained.
(xxxiv)(xlii) Performance
of a successful return demonstration for each health-related activity in which
developmental disabilities personnel are trained.
(xxxv)(xliii) Information
that health-related activities are performed only pursuant to nursing
delegation except for individuals:
(xxxvi)(xliv) Information
and instruction on the concepts underlying each step for performing
health-related activities according to current standards of safe practice,
including instruction in the correct and safe practices, procedures, and
techniques for performing health-related activities.
(xxxvii)(xlv) Instruction
in the usual parameters of health-related activities and instruction in the
course of action to be taken when parameters of health-related activities are
above or below those taught.
(xxxviii)(xlvi) Completion
of written examination pursuant to paragraph (D)(1)(d)
(E)(1)(d)
of this rule.
(xxxix)(xlvii)
Requirements for individual-specific training which shall
will occur
after certification and prior to administration of prescribed medication or
performance of health-related activities. The employer of developmental
disabilities personnel, the delegating nurse, or the county board
shall
will
ensure that developmental disabilities personnel receive individual-specific
training.
(i) A
review of an individual's right to self-administer medication, self-administer
medication with assistance, and participate in steps of medication
administration when not able to self-administer medication or self-administer
medication with assistance.
(ii)
Concepts of person-centered planning relevant to an individual's consent or
refusal
declination of prescribed medication.
(iii) Universal precautions for infection
control. The registered nurse trainer may waive the universal precautions for
infection control instruction material and instruction time of the program if
the developmental disabilities personnel can document training on that topic
within the previous year.
(iv) A
review of applicable federal and state drug laws and rules.
(v) Information and instruction on the
concepts underlying each step for correctly administering oral prescribed
medication, administering topical prescribed medication, administering topical
over-the-counter musculoskeletal medication, and administering oxygen and
metered dose inhaled medication according to current standards of safe
practice, procedures, and techniques.
(vi) Information and instruction to train the
developmental disabilities personnel to administer the right medication, at the
right dose, to the right individual, by the right route, at the right time and
with the right documentation.
(vii)
Written step-by-step directions on how to administer oral prescribed
medication, administer topical prescribed medication, administer topical
over-the-counter musculoskeletal medication, and administer oxygen and metered
dose inhaled medication.
(viii) Instruction in the
administration of oxygen as prescribed by a licensed health professional
authorized to prescribe drugs.
(ix)
Instruction in
taking vital signs (i.e., temperature, pulse, respiration, and blood
pressure).
(x)
Instruction in application of clean dressings that do
not require health assessment.
(xi)
Instruction in
basic measurement of bodily intake and output.
(xii)
Instruction in
oral suctioning.
(xiii)
Instruction in use of glucometers.
(xiv)
Instruction in
external urinary catheter care.
(xv)
Instruction in
emptying and replacing ostomy bags.
(xvi)
Instruction in
application of prescribed compression hosiery.
(xvii)
Instruction in
collection of specimens by noninvasive means.
(a) An intramuscular injection;
(b) An intravenous injection;
(c) A subcutaneous injection, except a
subcutaneous injection of insulin or prescribed medication for the treatment of
metabolic glycemic disorders, provided the developmental disabilities personnel
are trained and hold subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation
certification in accordance with this rule and the subcutaneous injection of
insulin or prescribed medication for the treatment of metabolic glycemic
disorders is delegated to a specific person by a licensed nurse pursuant to
section 5123.42 of the Revised Code and
this chapter;
(d) Any prescribed
medication administered through a nasogastric tube or an unstable or unlabeled
gastrostomy tube or an unstable or unlabeled jejunostomy tube; and
(e) Any debriding agent used in the treatment
of a skin condition or minor abrasion.
(a)
Receiving family support services or services from certified supported living
providers, if the services are offered or provided pursuant to Chapter 5123. or
Chapter 5126. of the Revised Code;
(b) Receiving residential support services
from certified home and community-based services providers, if the services are
received in a community living arrangement that includes no more than four
individuals;
(c) Residing in a
residential facility with five or fewer beds; or
(d) Receiving adult day services in a setting
where services are provided to sixteen or fewer individuals.
(2)
Prescribed medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation training program
(a) A prescribed medication
administration through feeding
gastrostomy and
jejunostomy tube by nursing delegation training program provided pursuant
to this rule to prepare developmental disabilities personnel to administer
prescribed medication through stable labeled gastrostomy and jejunostomy tubes
shall
will be
at a minimum a four-hour course and shall
will be in addition to the health-related
activities and prescribed medication administration training program described
in paragraph (B)(1)
(C)(1) of this rule; one hour equals sixty minutes of
classroom instruction. Relevant agency-specific and/or facility-specific
material may be added to the department-approved curriculum described in
paragraph (B)(2)(b)
(C)(2)(b) of this rule only with additional
corresponding classroom instruction time beyond the four-hour course.
Developmental disabilities personnel shall
will successfully complete the health-related
activities and prescribed medication administration training program described
in paragraph (B)(1)
(C)(1) of this rule prior to participating in the
prescribed medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation training program.
(b) The prescribed medication
administration through feeding
gastrostomy and
jejunostomy tube by nursing delegation training program
shall
will
address:
(i) Correct and safe practices,
procedures, and techniques for administering prescribed medication through
stable labeled gastrostomy and jejunostomy tubes, including possible signs and
symptoms of gastrostomy or jejunostomy tube malfunction or tube problems,
complication or intolerance of prescribed medication by the individual, and
appropriate response to a gastrostomy or jejunostomy tube that becomes
dislodged.
(ii) Requirements for
documentation of prescribed medication administered, missed, held, or
refused
declined to, by, or for each individual through stable
labeled gastrostomy or jejunostomy tube.
(iii) Requirements for documentation and
notification of prescribed medication errors through stable labeled gastrostomy
or jejunostomy tube.
(iv)
Information regarding the proper storage, care, and preparation of prescribed
medication to be administered through stable labeled gastrostomy or jejunostomy
tube.
(v) Information regarding the
proper storage and care of gastrostomy and jejunostomy tubes.
(vi) Requirements for nursing delegation of
prescribed medication administration through stable labeled gastrostomy and
jejunostomy tubes.
(vii)
Instruction that only the delegating nurse shall
or a licensed nurse
in coordination/communication with the delegating nurse will receive
prescriptions for prescribed medication to be administered through stable
labeled gastrostomy or jejunostomy tube and only the delegating nurse
shall
or a licensed
nurse in coordination/communication with the delegating nurse will
transcribe these prescriptions into a
prescribed
on to a medication
administration record or treatment administration record.
(viii) Performance of successful return
demonstration of proficiency in administering prescribed medication through
stable labeled gastrostomy and jejunostomy tubes.
(ix) Completion of written examination
pursuant to paragraph (D)(1)(d)
(E)(1)(d) of this rule.
(x) Requirements for individual-specific
training which shall
will occur after certification and prior to
administration of prescribed medication through stable labeled gastrostomy or
jejunostomy tube. The delegating nurse shall
be
is responsible for the
individual-specific training.
(3)
Subcutaneous
injection
Administration of insulin and
medication for the treatment of metabolic glycemic disorders by nursing
delegation training program
(a)
A subcutaneous injection
An administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation training
program provided pursuant to this rule to prepare developmental disabilities
personnel to administer insulin through
subcutaneous injection,
of insulin
inhalation, and insulin pump and
administer prescribed medication for the
treatment of metabolic glycemic disorders through
subcutaneous injection by nursing delegation shall
will be a
minimum a four-hour course and shall
will be in addition to the health-related
activities and prescribed medication administration training program described
in paragraph (B)(1)
(C)(1) of this rule; one hour equals sixty minutes of
classroom instruction. Relevant agency-specific and/or facility-specific
material may be added to the department-approved curriculum described in
paragraph (B)(3)(b)
(C)(3)(b) of this rule only with additional
corresponding classroom instruction time beyond the four-hour course.
Developmental disabilities personnel shall
will successfully complete the health-related
activities and prescribed medication administration training program described
in paragraph (B)(1)
(C)(1) of this rule prior to participating in the
subcutaneous injection
administration of insulin and medication for the treatment
of metabolic glycemic disorders by nursing delegation training
program.
(b) The
subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation training
program shall
will address:
(i)
Information on the basic pathophysiology of metabolic glycemic
disorders.
(ii) Correct and safe
practices, procedures, and techniques for administering insulin and subcutaneous injections, possible signs
and symptoms of subcutaneous injection complication, and instruction in safe
handling and disposal of sharps.
(iii) The requirements for documentation of
subcutaneous injections administered, missed, held, or
refused
declined to, by, or for each individual.
(iv) Requirements for documentation and
notification of prescribed medication errors and
subcutaneous injection errors.
(v)
Information regarding the proper storage, care, and preparation of insulin or
prescribed medication for treatment of metabolic glycemic disorders to be
administered by subcutaneous injection.
(vi) Signs and symptoms of hypoglycemia and
hyperglycemia and procedure for intervention and notification of nurse,
physician, or emergency medical services.
(vii) Instruction in the use of commercially
packaged glucagon for the treatment of hypoglycemia as prescribed by a licensed
health professional authorized to prescribe drugs. Teaching must be completed
and nursing delegation must be in place prior to administration of
glucagon.
(viii) Instruction that
only the delegating nurse or a licensed nurse
shall
in
coordination/communication with the delegating nurse will transcribe a
prescription for insulin or prescribed medication for treatment of metabolic
glycemic disorders on to a prescribed
medication administration record.
(ix) Performance of successful return
demonstration of proficiency in administering insulin
and subcutaneous injections.
(x) Completion of written examination
pursuant to paragraph (D)(1)(d)
(E)(1)(d) of this rule.
(xi) Requirements for nursing delegation of
subcutaneous injections of insulin and prescribed
medication for the treatment of metabolic glycemic disorders
administration of insulin through subcutaneous
injection, inhalation, and insulin pump and administration of prescribed
medication for the treatment of metabolic glycemic disorders through
subcutaneous injection.
(xii)
Requirements for individual-specific training which shall
will occur
after certification and prior to administration of subcutaneous injections of insulin
through subcutaneous injection, inhalation, and insulin
pump and administration of prescribed
medication for the treatment of metabolic glycemic disorders
through subcutaneous injection. The delegating
nurse shall be
is responsible for the individual-specific
training.
(1) The health-related
activities and prescribed medication administration training program, the
prescribed medication administration through
feeding
gastrostomy
or jejunostomy tube by nursing delegation training program, and the
subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation training
program shall
will be planned, developed, and delivered by a
registered nurse trainer certified by the department in accordance with rule
5123:2-6-04
5123-6-04 of the Administrative Code. The registered
nurse trainer shall
will ensure that training programs are conducted in
accordance with requirements set forth in this chapter.
(2) A registered nurse trainer
shall
will
use only a department-approved curriculum for the health-related activities and
prescribed medication administration training program, the prescribed
medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation training program, or the
subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation training
program.
(3) A registered nurse
trainer shall
will personally conduct the majority of a training
program but may utilize other licensed health professionals to assist with
conducting the training program as long as the other licensed health
professionals have received instruction on the material and are acting within
their professional scope of practice as outlined in the Revised Code.
(1) To receive initial certification in
health-related activities and prescribed medication administration, prescribed
medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation, or subcutaneous injection
administration of insulin and medication for the treatment
of metabolic glycemic disorders by nursing delegation, developmental
disabilities personnel shall
will:
(a) Attend
the entire applicable training program.
(b) Actively participate in the training
program class discussions and activities.
(c) Successfully perform a return
demonstration of proficiency.
(d)
Complete the closed book final written examination for the training program
with a score of at least eighty per cent. Developmental disabilities personnel
scoring less than eighty per cent on the final written examination
shall
will
retake the training program in its entirety to be eligible to retake the final
written examination. The final written examination developed and maintained by
the department shall
will be the only final written examination
used.
(e) Complete and submit to
the registered nurse trainer the evaluation of the training program.
(2) Certification in
health-related activities and prescribed medication administration is a
prerequisite for certification in prescribed medication administration through feeding
gastrostomy and
jejunostomy tube by nursing delegation or certification in
subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing
delegation.
(3) The registered
nurse trainer shall
will ensure developmental disabilities personnel meet
all requirements for initial certification before indicating so in the
medication administration information system database.
(1) To maintain certification in
health-related activities and prescribed medication administration, prescribed
medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation, or subcutaneous injection
administration of insulin and medication for the treatment
of metabolic glycemic disorders by nursing delegation, developmental
disabilities personnel shall
will annually complete continuing education that
will enhance the role of developmental disabilities personnel who have
completed the training program as determined by the registered nurse trainer.
Developmental disabilities personnel shall
will provide documentation of completion of the
required continuing education to the registered nurse trainer.
(a) To maintain certification in
health-related activities and prescribed medication administration,
developmental disabilities personnel shall
will annually
complete at least two hours of continuing education that relates to the
information taught in the health-related activities and prescribed medication
administration training program (as determined by the registered nurse trainer)
and perform a successful return demonstration of skills.
(b) To maintain certification in prescribed
medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation, developmental disabilities
personnel shall
will annually complete at least one hour of continuing
education that relates to the information taught in the prescribed medication
administration through feeding
gastrostomy and
jejunostomy tube by nursing delegation training program (as determined by
the registered nurse trainer) and perform a successful return demonstration of
skills. The continuing education required in this paragraph is in addition to
the two hours of continuing education required for health-related activities
and prescribed medication administration certification and, if applicable, the
one hour of continuing education required for subcutaneous injection
administration of insulin and medication for the treatment
of metabolic glycemic disorders by nursing delegation
certification.
(c) To maintain
certification in subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation, the
developmental disabilities personnel shall
will annually complete at least one hour of
continuing education that relates to the information taught in the
subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing delegation training
program (as determined by the registered nurse trainer) and perform a
successful return demonstration of skills. The continuing education required in
this paragraph is in addition to the two hours of continuing education required
for health-related activities and prescribed medication administration
certification and, if applicable, the one hour of continuing education required
for prescribed medication administration through
feeding
gastrostomy
and jejunostomy tube by nursing delegation certification.
(2) Training in cardiopulmonary
resuscitation, first aid, activation of a vagus nerve stimulator, use of an
epinephrine auto-injector, administration of topical over-the-counter
medication, or universal precautions for infection control
shall
will
not count toward continuing education required by paragraph
(E)(1)(a), (E)(1)(b), or (E)(1)(c)
(F)(1)(a), (F)(1)(b), or (F)(1)(c) of this
rule.
(3) Maintaining certification
in health-related activities and prescribed medication administration is
required to maintain certification in prescribed medication
administration through feeding
gastrostomy and
jejunostomy tube by nursing delegation and certification in
subcutaneous injection
administration of insulin and medication for the
treatment of metabolic glycemic disorders by nursing
delegation.
(4) When developmental
disabilities personnel fail to complete the required continuing education and
return demonstration of skills by the annual certification expiration date, the
certification of the developmental disabilities personnel
shall
will be
temporarily inactive for a maximum period of sixty calendar days, during which
time the developmental disabilities personnel shall
will complete
the required continuing education and return demonstration of skills. If the
developmental disabilities personnel fail to complete the required continuing
education and return demonstration of skills within the sixty-day suspension
period, the developmental disabilities personnel shall
will be
required to repeat each training program in its entirety to become
recertified.
(5) While the
certification of developmental disabilities personnel is temporarily inactive
in accordance with paragraph (E)(4)
(F)(4) of this rule, the developmental
disabilities personnel shall
will not:
(a)
Perform health-related activities;
(b) Administer oral prescribed
medication;
(c) Administer topical
prescribed medication;
(d)
Administer topical over-the-counter musculoskeletal medication;
(e) Administer oxygen or metered dose inhaled
medication;
(f) Administer
prescribed medication through gastrostomy or jejunostomy tubes;
(g) Receive nursing delegation to administer
prescribed medication through gastrostomy or jejunostomy tubes;
(h) Administer prescribed insulin through
subcutaneous injection, inhalation, or insulin pump;
(i) Receive nursing delegation to administer
prescribed insulin through subcutaneous injection, inhalation, or insulin
pump;
(j) Administer prescribed
medication for the treatment of metabolic glycemic disorders through
subcutaneous injection; or
(k)
Receive nursing delegation to administer prescribed medication for the
treatment of metabolic glycemic disorders through subcutaneous
injection.
(6) The
registered nurse trainer shall
will ensure developmental disabilities personnel
meet all requirements for renewal certification before indicating so in the
medication administration information system database.
Notes
Promulgated Under: 119.03
Statutory Authority: 5123.04, 5123.42, 5123.43, 5123.45, 5123.46
Rule Amplifies: 5123.04, 5123.41 to 5123.47
Prior Effective Dates: 09/30/1993 (Emer.), 12/29/1993, 05/16/1994 (Emer.), 08/06/1994, 06/30/1995, 02/14/2000, 10/22/2003 (Emer.), 01/08/2004, 06/01/2016, 11/06/2017, 01/14/2021
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.